drugset / Trial / NCT01469273

Prophylaxis of Gastrointestinal Infections With EcN

NCT01469273 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

This interventional trial shall investigate the efficacy and tolerance of a suspension with non-pathogenic probiotic E. coli strain Nissle (EcN) on prophylaxis against gastrointestinal infections in newborn and infants. ECN-SUSPENSION is a probiotic containing viable E. coli bacteria of the non-pathogenic Nissle 1917 strain at a concentration of 10exp8 cells per ml.

Timeline

Start
2011-11
Primary completion
2013-05
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nissle 1917 Other / unclassified 1 ml —

Indications